Pharma Mar, S.A.

Tweet this page
<
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 26 Mar 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

10,000€ - 24,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Pharma Mar, S.A.   (PharmaMar)

    EU Transparency Register

    840804329063-93 First registered on 22 Nov 2017

    Goals / Remit

    PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. PharmaMar’s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin.

    Main EU files targeted

    European Medicines Agency activities
    Industrial policy
    Research policy
    Public funding for research

    Address

    Head Office
    Av. de los Reyes, 1 Colmenar Viejo
    MADRID 28770
    SPAIN
    EU Office
    Plaza del Descubridor Diego de Ordás 3
    Madrid 28003
    SPAIN

    Website

    http://www.pharmamar.com

  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Spanish Association for Biotechnology
    www.asebio.com

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    10,000€ - 24,999€

    Major contributions in closed year

    TypeNameAmount
    Grant Horizon Europe 156,916€

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    10,000€ - 24,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Horizon Europe
    Drug Approval procedures

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 24 Nov 2017 Location Brussels
      Subject Pharmaceutical policy
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
      • Vytenis Andriukaitis (Commissioner)
      Other Lobbyists
Download this datacard